Prothena Corporation plc
PRTA
$9.60
$0.171.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -57.99% | -92.83% | -91.16% | -95.24% | 54.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.99% | -92.83% | -91.16% | -95.24% | 54.55% |
| Cost of Revenue | -53.80% | -39.40% | -27.24% | -20.38% | -12.80% |
| Gross Profit | 45.67% | -43.28% | -57.26% | -652.14% | 52.69% |
| SG&A Expenses | -19.12% | -11.62% | -5.49% | -0.09% | 2.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.35% | -32.95% | -22.38% | -15.96% | -9.47% |
| Operating Income | 32.77% | -19.41% | -32.15% | -172.55% | 35.90% |
| Income Before Tax | 7.88% | -55.77% | -70.48% | -326.21% | 37.42% |
| Income Tax Expenses | 894.03% | 753.52% | 607.58% | 493.78% | 56.07% |
| Earnings from Continuing Operations | -37.10% | -99.57% | -112.74% | -494.87% | 36.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.10% | -99.57% | -112.74% | -494.87% | 36.04% |
| EBIT | 32.77% | -19.41% | -32.15% | -172.55% | 35.90% |
| EBITDA | 32.95% | -19.52% | -32.36% | -174.43% | 36.04% |
| EPS Basic | -37.06% | -99.35% | -112.23% | -492.98% | 36.41% |
| Normalized Basic EPS | 30.22% | -32.29% | -46.50% | -271.98% | 37.78% |
| EPS Diluted | -35.98% | -97.50% | -110.39% | -462.14% | 36.23% |
| Normalized Diluted EPS | 30.93% | -30.76% | -44.94% | -254.91% | 37.46% |
| Average Basic Shares Outstanding | 0.00% | 0.11% | 0.17% | 0.26% | 0.53% |
| Average Diluted Shares Outstanding | -0.41% | -0.48% | -0.42% | -2.35% | -0.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |